Among the molecular markers evaluated through IHC, a sparsely granulated pattern, Ki-67 index ≥3%, and reduced E-Cadherin expression have been linked to enhanced invasiveness, lower surgical remission rates, and a risk of recurrence in corticotropinomas. Here, CDH1 is linked to ACTH-producing pituitary gland adenoma.